Search

Search Results
Results 25661 - 25670 of 25785 for AIDS
  • Drug - 3 Aug 2022
    Consumer Medicine Information (CMI) about Glivec Tablets intended for persons living in Australia.
  • Drug - 20 Jun 2022
    Consumer Medicine Information (CMI) about DBL Pentamidine Isethionate intended for persons living in Australia.
  • White Paper - 30 May 2022
    Parkinson’s disease is the second most common neurodegenerative disease. As it continues to affect more and more people, there’s massive demand for continued and new research into novel and...
  • Drug - 5 Apr 2022
    Consumer Medicine Information (CMI) about Zykadia intended for persons living in Australia.
  • White Paper - 23 Feb 2022
    Discover more about the analysis of additives in diet soft drinks with green chemistry.
  • Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Drug - 17 Dec 2021
    Consumer Medicine Information (CMI) about Navelbine IV intended for persons living in Australia.
  • Drug - 17 Dec 2021
    Consumer Medicine Information (CMI) about Navelbine Oral intended for persons living in Australia.
  • White Paper - 10 Nov 2021
    Anti-idiotypic antibodies, often known as anti-drug antibodies, are important references for immunogenicity analysis. They are incredibly useful in pharmacokinetics research. ACROBiosystems offers a...
  • Drug - 3 Nov 2021
    Consumer Medicine Information (CMI) about Panamax intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.